Join MySLAS Social

Special Issue

3D Cell Culture, Drug Screening and Optimization

Free access to select papers courtesy of Corning Life Sciences

By Guest Editors Richard Eglen and Jean-Louis Klein

Richard Eglen, Ph.D.
Corning Life Sciences
Corning Inc.
Tewksbury, MA  USA

 

Jean-Louis Klein, Ph.D.
GlaxoSmithKline
Philadelphia, PA  USA

 

 

The June 2017 issue of SLAS Discovery (formerly the Journal of Biomolecular Screening) showcases three-dimensional (3D) cell culture as a rapidly emerging approach to cellular science and drug discovery.

Seventeen rigorously peer-reviewed scientific reports and an editorial introduction by guest editors Richard Eglen, Ph.D. (Corning Life Sciences) and Jean-Louis Klein, Ph.D. (GlaxoSmithKline) offer an overview of the topic’s historical development and insight into novel technologies that are now emerging for drug discovery, including, novel surfaces, organ-on-a-chip methods and bioprinting.

The original scientific reports in this special issue of SLAS Discovery address achievements ranging from 3D cell culture applications in cancer research to the use of multicellular spheroids as 3D cell models, use of imaging technologies, 3D culture with organoids, and novel applications for hydrogel-based surfaces.

Free public access to selected reports in this special issue is sponsored by Corning Life Sciences.

 

Editorial
 
Review
 
Original Research

 

Read the Issue!


SLAS publishes two MEDLINE-indexed journals and accepts manuscripts on an ongoing basis from members and non-members.  > READ MORE

May 22, 2017